- Home
- SEER vs NAKA Comparison
SEER vs NAKA Comparison
Compare SEER & NAKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- NAKA
- Stock Information
- Founded
- SEER 2017
- NAKA 2019
- Country
- SEER United States
- NAKA United States
- Employees
- SEER N/A
- NAKA N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- NAKA
- Sector
- SEER Health Care
- NAKA
- Exchange
- SEER Nasdaq
- NAKA Nasdaq
- Market Cap
- SEER 125.3M
- NAKA 126.6M
- IPO Year
- SEER 2020
- NAKA 2024
- Fundamental
- Price
- SEER $2.01
- NAKA $14.22
- Analyst Decision
- SEER Hold
- NAKA
- Analyst Count
- SEER 1
- NAKA 0
- Target Price
- SEER $3.00
- NAKA N/A
- AVG Volume (30 Days)
- SEER 416.0K
- NAKA 1.7M
- Earning Date
- SEER 08-07-2025
- NAKA 08-13-2025
- Dividend Yield
- SEER N/A
- NAKA N/A
- EPS Growth
- SEER N/A
- NAKA N/A
- EPS
- SEER N/A
- NAKA N/A
- Revenue
- SEER $15,309,000.00
- NAKA $2,470,466.00
- Revenue This Year
- SEER $26.18
- NAKA N/A
- Revenue Next Year
- SEER $29.58
- NAKA N/A
- P/E Ratio
- SEER N/A
- NAKA N/A
- Revenue Growth
- SEER N/A
- NAKA N/A
- 52 Week Low
- SEER $1.56
- NAKA $0.65
- 52 Week High
- SEER $2.63
- NAKA $34.77
- Technical
- Relative Strength Index (RSI)
- SEER 46.09
- NAKA N/A
- Support Level
- SEER $2.10
- NAKA N/A
- Resistance Level
- SEER $2.13
- NAKA N/A
- Average True Range (ATR)
- SEER 0.10
- NAKA 0.00
- MACD
- SEER -0.02
- NAKA 0.00
- Stochastic Oscillator
- SEER 16.67
- NAKA 0.00
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About NAKA Kindly MD Inc. Common Stock
Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.